H.C. Wainwright Maintains Its Bullish Stance on Vera Therapeutics (VERA), Sees Strong Future Revenue Growth

Vera Therapeutics, Inc. (NASDAQ:VERA) is 1 of the best small-cap biotech stocks to bargain according to analysts.

A doc administering a diagnostic trial kit for the detection of gastrointestinal diseases.

On November 10, 2025, The Fly reported that H.C. Wainwright accrued its terms people connected Vera Therapeutics, Inc. (NASDAQ:VERA) from $85 to $90, portion maintaining a “Buy” rating. The bullish stance reflects the company’s presumption of findings from its ongoing ORIGIN 3 survey with atacicept. The concern steadfast expects a 95% likelihood of atacicept’s motorboat successful IgA nephropathy (IgAN), anticipating the cause to make $56 cardinal successful gross successful the archetypal year, with maturation to $2.5 cardinal by 2033.

On November 6, 2025, Vera Therapeutics, Inc. (NASDAQ:VERA) presented palmy Phase 3 proceedings results for its late-stage kidney illness treatment. The data, presented astatine the American Society of Nephrology Kidney Week, revealed a 46% alteration successful proteinuria on with beardown information outcomes. These results item the imaginable of this therapy to amended the absorption of chronic renal diseases. To measure the study’s interaction and program forthcoming regulatory actions, the institution hosted an in-depth league telephone with cardinal sentiment leaders.

The announcement strengthened capitalist assurance and suggested increasing regulatory progress, with Vera advancing towards filing its Biologics License Application (BLA) for U.S. review. The company’s coagulated objective results were validated by peer-reviewed recognition, reinforcing its credibility successful nephrology and perchance paving the mode for wider marketplace acceptance erstwhile the therapy is launched.

Vera Therapeutics, Inc. (NASDAQ:VERA) is focused connected processing therapies for terrible immunological and renal diseases.

While we admit the imaginable of VERA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Oil and Gas Penny Stocks to Buy According to Analysts and Billionaire Jacob Rothschild’s RIT Capital Partners: 9 Stocks with Huge Upside Potential.

Disclosure: None.